{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T04:34:20Z","timestamp":1747802060153,"version":"3.41.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,20]]},"DOI":"10.7759\/cureus.84492","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T19:52:46Z","timestamp":1747770766000},"source":"Crossref","is-referenced-by-count":0,"title":["A Rare Presentation of Priapism From Pegylated Filgrastim During Treatment of Urothelial Cancer in an African-American Patient With Sickle Cell Trait"],"prefix":"10.7759","author":[{"given":"Nikhita","family":"Kathuria-Prakash","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leland","family":"Damron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandy C","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven  D","family":"Hart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Drakaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/1757-1626-1-429","article-title":"Sickle cell trait and priapism: a case report and review of the literature","volume":"1","author":"Birnbaum BF","year":"2008","unstructured":"Birnbaum BF, Pinzone JJ. Sickle cell trait and priapism: a case report and review of the literature. Cases J. 2008, 1:429. 10.1186\/1757-1626-1-429","journal-title":"Cases J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021004338","article-title":"Stuttering priapism in a patient with sickle cell trait treated with automated red cell exchange transfusion","volume":"5","author":"Ebraheem MS","year":"2021","unstructured":"Ebraheem MS, Verhovsek M. Stuttering priapism in a patient with sickle cell trait treated with automated red cell exchange transfusion. Blood Adv. 2021, 5:5020-2. 10.1182\/bloodadvances.2021004338","journal-title":"Blood Adv"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1177\/0141076816651037","article-title":"Risk of individual malignant neoplasms in patients with sickle cell disease: English national record linkage study","volume":"109","author":"Seminog OO","year":"2016","unstructured":"Seminog OO, Ogunlaja OI, Yeates D, Goldacre MJ. Risk of individual malignant neoplasms in patients with sickle cell disease: English national record linkage study. J R Soc Med. 2016, 109:303-9. 10.1177\/0141076816651037","journal-title":"J R Soc Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.14740\/jh958","article-title":"Sickle cell trait: is it always benign?","volume":"12","author":"Brown TS","year":"2023","unstructured":"Brown TS, Lakra R, Master S, Ramadas P. Sickle cell trait: is it always benign?. J Hematol. 2023, 12:123-7. 10.14740\/jh958","journal-title":"J Hematol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2008.12.020","article-title":"Complications associated with sickle cell trait: a brief narrative review","volume":"122","author":"Tsaras G","year":"2009","unstructured":"Tsaras G, Owusu-Ansah A, Boateng FO, Amoateng-Adjepong Y. Complications associated with sickle cell trait: a brief narrative review. Am J Med. 2009, 122:507-12. 10.1016\/j.amjmed.2008.12.020","journal-title":"Am J Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020002062","article-title":"Men with sickle cell disease experience greater sexual dysfunction when compared with men without sickle cell disease","volume":"4","author":"Idris IM","year":"2020","unstructured":"Idris IM, Abba A, Galadanci JA, et al.. Men with sickle cell disease experience greater sexual dysfunction when compared with men without sickle cell disease. Blood Adv. 2020, 4:3277-83. 10.1182\/bloodadvances.2020002062","journal-title":"Blood Adv"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2009.01625.x","article-title":"Priapism: pathogenesis, epidemiology, and management","volume":"7","author":"Broderick GA","year":"2010","unstructured":"Broderick GA, Kadioglu A, Bivalacqua TJ, Ghanem H, Nehra A, Shamloul R. Priapism: pathogenesis, epidemiology, and management. J Sex Med. 2010, 7:476-500. 10.1111\/j.1743-6109.2009.01625.x","journal-title":"J Sex Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2022000380","article-title":"Epidemiology and treatment of priapism in sickle cell disease","volume":"2022","author":"Idris IM","year":"2022","unstructured":"Idris IM, Burnett AL, DeBaun MR. Epidemiology and treatment of priapism in sickle cell disease. Hematology Am Soc Hematol Educ Program. 2022, 2022:450-8. 10.1182\/hematology.2022000380","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2011.02288.x","article-title":"New insights into the pathophysiology of sickle cell disease-associated priapism","volume":"9","author":"Bivalacqua TJ","year":"2012","unstructured":"Bivalacqua TJ, Musicki B, Kutlu O, Burnett AL. New insights into the pathophysiology of sickle cell disease-associated priapism. J Sex Med. 2012, 9:79-87. 10.1111\/j.1743-6109.2011.02288.x","journal-title":"J Sex Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S0162-3109(99)00036-3","article-title":"Inhibition of inducible nitric oxide synthase gene expression and nitric oxide synthesis in vascular smooth muscle cells by granulocyte-colony stimulating factor in vitro","volume":"43","author":"Deetjen C","year":"1999","unstructured":"Deetjen C, Frede S, Smolny M, Seibel M, Schobersberger W, Hoffmann G. Inhibition of inducible nitric oxide synthase gene expression and nitric oxide synthesis in vascular smooth muscle cells by granulocyte-colony stimulating factor in vitro. Immunopharmacology. 1999, 43:23-30. 10.1016\/S0162-3109(99)00036-3","journal-title":"Immunopharmacology"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.14335","article-title":"Thalassemia and priapism: a literature review of a rare association","volume":"13","author":"Sardar S","year":"2021","unstructured":"Sardar S, Ali EA, Yassin MA. Thalassemia and priapism: a literature review of a rare association. Cureus. 2021, 13:e14335. 10.7759\/cureus.14335","journal-title":"Cureus"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022007285","article-title":"Incidence and predictors of priapism events in sickle cell anemia: a\u00a0diary-based analysis","volume":"6","author":"Idris IM","year":"2022","unstructured":"Idris IM, Abba A, Galadanci JA, et al.. Incidence and predictors of priapism events in sickle cell anemia: a\u00a0diary-based analysis. Blood Adv. 2022, 6:5676-83. 10.1182\/bloodadvances.2022007285","journal-title":"Blood Adv"},{"key":"ref13","unstructured":"Administration FaD. Neulasta Prescribing Information. (2018). Accessed. December 10, 2024: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/125031s198lbl.pdf."},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/146938","article-title":"Safety of pegfilgrastim (neulasta) in patients with sickle cell trait\/anemia","volume":"2013","author":"Kasi PM","year":"2013","unstructured":"Kasi PM, Patnaik MM, Peethambaram PP. Safety of pegfilgrastim (neulasta) in patients with sickle cell trait\/anemia. Case Rep Hematol. 2013, 2013:146938. 10.1155\/2013\/146938","journal-title":"Case Rep Hematol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000002767","article-title":"The diagnosis and management of recurrent ischemic priapism, priapism in sickle cell patients, and non-ischemic priapism: an AUA\/SMSNA Guideline","volume":"208","author":"Bivalacqua TJ","year":"2022","unstructured":"Bivalacqua TJ, Allen BK, Brock GB, et al.. The diagnosis and management of recurrent ischemic priapism, priapism in sickle cell patients, and non-ischemic priapism: an AUA\/SMSNA Guideline. J Urol. 2022, 208:43-52. 10.1097\/JU.0000000000002767","journal-title":"J Urol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-09-551887","article-title":"How I treat priapism","volume":"125","author":"Anele UA","year":"2015","unstructured":"Anele UA, Le BV, Resar LM, Burnett AL. How I treat priapism. Blood. 2015, 125:3551-8. 10.1182\/blood-2014-09-551887","journal-title":"Blood"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/326658-a-rare-presentation-of-priapism-from-pegylated-filgrastim-during-treatment-of-urothelial-cancer-in-an-african-american-patient-with-sickle-cell-trait","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T19:52:47Z","timestamp":1747770767000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/326658-a-rare-presentation-of-priapism-from-pegylated-filgrastim-during-treatment-of-urothelial-cancer-in-an-african-american-patient-with-sickle-cell-trait"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,20]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.84492","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,20]]}}}